Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report.

Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M.

Clin Toxicol (Phila). 2014 Dec;52(10):1032-283. doi: 10.3109/15563650.2014.987397.

2.

Poisoning in the United States: 2012 emergency medicine report of the National Poison Data System.

Dart RC, Bronstein AC, Spyker DA, Cantilena LR, Seifert SA, Heard SE, Krenzelok EP.

Ann Emerg Med. 2015 Apr;65(4):416-22. doi: 10.1016/j.annemergmed.2014.11.001. Epub 2014 Dec 15.

PMID:
25523411
3.

Evidence-based evaluation of potential benefits and safety of beta-alanine supplementation for military personnel.

Ko R, Low Dog T, Gorecki DK, Cantilena LR, Costello RB, Evans WJ, Hardy ML, Jordan SA, Maughan RJ, Rankin JW, Smith-Ryan AE, Valerio LG Jr, Jones D, Deuster P, Giancaspro GI, Sarma ND.

Nutr Rev. 2014 Mar;72(3):217-25. Review.

PMID:
24697258
4.

2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.

Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M.

Clin Toxicol (Phila). 2013 Dec;51(10):949-1229. doi: 10.3109/15563650.2013.863906.

PMID:
24359283
5.

2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.

Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC.

Clin Toxicol (Phila). 2012 Dec;50(10):911-1164. doi: 10.3109/15563650.2012.746424. Erratum in: Clin Toxicol (Phila). 2014 Dec;52(10):1286-7.

PMID:
23272763
6.

Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study.

Miller RS, Li Q, Cantilena LR, Leary KJ, Saviolakis GA, Melendez V, Smith B, Weina PJ.

Malar J. 2012 Aug 1;11:255. doi: 10.1186/1475-2875-11-255.

7.

2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.

Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC.

Clin Toxicol (Phila). 2011 Dec;49(10):910-41. doi: 10.3109/15563650.2011.635149. Erratum in: Clin Toxicol (Phila). 2014 Dec;52(10):1285.

PMID:
22165864
8.

Assessment of the relative potency of fentanyl buccal tablet to intravenous morphine in healthy volunteers using a thermally induced hyperalgesia pain model.

Saunders DL, Messina J, Darwish M, Xie F, Leary KJ, Cantilena LR.

J Clin Pharmacol. 2012 Jun;52(6):870-9. doi: 10.1177/0091270011407496. Epub 2011 Jun 6.

PMID:
21646442
9.

2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.

Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL.

Clin Toxicol (Phila). 2010 Dec;48(10):979-1178. doi: 10.3109/15563650.2010.543906. Erratum in: Clin Toxicol (Phila). 2014 Dec;52(10):1284.

PMID:
21192756
10.

2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.

Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL.

Clin Toxicol (Phila). 2009 Dec;47(10):911-1084. doi: 10.3109/15563650903438566.

PMID:
20028214
11.

Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study.

Li Q, Cantilena LR, Leary KJ, Saviolakis GA, Miller RS, Melendez V, Weina PJ.

Am J Trop Med Hyg. 2009 Oct;81(4):615-21. doi: 10.4269/ajtmh.2009.09-0150.

PMID:
19815876
12.

A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.

Leary KJ, Riel MA, Roy MJ, Cantilena LR, Bi D, Brater DC, van de Pol C, Pruett K, Kerr C, Veazey JM Jr, Beboso R, Ohrt C.

Am J Trop Med Hyg. 2009 Aug;81(2):356-62.

PMID:
19635898
13.

2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report.

Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE; American Association of Poison Control Centers.

Clin Toxicol (Phila). 2008 Dec;46(10):927-1057. doi: 10.1080/15563650802559632.

PMID:
19065310
14.

2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).

Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE.

Clin Toxicol (Phila). 2007 Dec;45(8):815-917.

PMID:
18163234
15.

High performance liquid chromatographic measurement of iothalamate in human serum and urine for evaluation of glomerular filtration rate.

Bi D, Leary KJ, Weitz JA, Cherstniakova SA, Reil MA, Roy MJ, Cantilena LR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):95-9. Epub 2007 Jun 6.

PMID:
17599846
16.

Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trials.

Cantilena LR, Cherstniakova SA, Saviolakis G, Kahn R, Elkashef A, Rose L, Vocci F.

Contemp Clin Trials. 2007 Nov;28(6):695-704. Epub 2007 Mar 19.

PMID:
17544338
17.

Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.

Roy MJ, Kraus PL, Seegers CA, Young SY, Kamens DR, Law WA, Cherstniakova SA, Chang DN, Cooper JA, Sato PA, Matulich W, Krantz DS, Cantilena LR, Deuster PA.

Mayo Clin Proc. 2006 Oct;81(10):1303-10.

PMID:
17036555
18.
19.

The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.

Knudsen JF, Carlsson U, Hammarström P, Sokol GH, Cantilena LR.

Inflammation. 2004 Oct;28(5):285-90.

PMID:
16134002
20.

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval.

Beasley CM Jr, Mitchell MI, Dmitrienko AA, Emmick JT, Shen W, Costigan TM, Bedding AW, Turik MA, Bakhtyari A, Warner MR, Ruskin JN, Cantilena LR Jr, Kloner RA.

J Am Coll Cardiol. 2005 Aug 16;46(4):678-87.

21.

Metabolism by N-acetyltransferase 1 in vitro and in healthy volunteers: a prototype for targeted inhibition.

Cantilena LR, Katki AG, Klecker RW, Collins JM.

J Clin Pharmacol. 2004 Dec;44(12):1405-11.

PMID:
15545312
22.

Drug-induced torsades de pointes and implications for drug development.

Fenichel RR, Malik M, Antzelevitch C, Sanguinetti M, Roden DM, Priori SG, Ruskin JN, Lipicky RJ, Cantilena LR; Independent Academic Task Force.

J Cardiovasc Electrophysiol. 2004 Apr;15(4):475-95. Review.

23.

Adverse events following discharge from the hospital.

Medlock MM, Cantilena LR Jr, Riel MA.

Ann Intern Med. 2004 Feb 3;140(3):231-2; author reply 232-3. No abstract available.

PMID:
14757626
24.

Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.

Cherstniakova SA, Bi D, Fuller DR, Mojsiak JZ, Collins JM, Cantilena LR.

Drug Metab Dispos. 2001 Sep;29(9):1216-20.

PMID:
11502731
25.

Assessment and reporting of clinical pharmacology information in drug labeling.

Spyker DA, Harvey ED, Harvey BE, Harvey AM, Rumack BH, Peck CC, Atkinson AJ Jr, Woosley RL, Abernethy DR, Cantilena LR.

Clin Pharmacol Ther. 2000 Mar;67(3):196-200. No abstract available.

PMID:
10741621
26.

The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: a meta-analysis.

D'Agostino RB Sr, Weintraub M, Russell HK, Stepanians M, D'Agostino RB Jr, Cantilena LR Jr, Graumlich JF, Maldonado S, Honig P, Anello C.

Clin Pharmacol Ther. 1998 Dec;64(6):579-96. No abstract available.

PMID:
9871423
27.

A drug interaction between zafirlukast and theophylline.

Katial RK, Stelzle RC, Bonner MW, Marino M, Cantilena LR, Smith LJ.

Arch Intern Med. 1998 Aug 10-24;158(15):1713-5.

PMID:
9701106
28.

Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.

Graumlich JF, Ludden TM, Conry-Cantilena C, Cantilena LR Jr, Wang Y, Levine M.

Pharm Res. 1997 Sep;14(9):1133-9.

PMID:
9327438
29.

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.

Takimoto CH, Dahut W, Marino MT, Nakashima H, Liang MD, Harold N, Lieberman R, Arbuck SG, Band RA, Chen AP, Hamilton JM, Cantilena LR, Allegra CJ, Grem JL.

J Clin Oncol. 1997 Apr;15(4):1492-501.

PMID:
9193345
30.

Clinical pharmacology of 9-aminocamptothecin.

Takimoto CH, Dahut W, Harold N, Nakashima H, Lieberman R, Liang MD, Arbuck SG, Chen AP, Hamilton JM, Cantilena LR, Allegra CJ, Grem JL.

Ann N Y Acad Sci. 1996 Dec 13;803:324-6. No abstract available.

PMID:
8993530
31.

Survey of clinical pharmacology training in the United States and Canada.

Cantilena LR Jr, Woosley RL.

Clin Pharmacol Ther. 1996 Jul;60(1):1-7.

PMID:
8689805
32.

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3704-9.

33.

Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine.

Honig PK, Wortham DC, Lazarev A, Cantilena LR.

J Clin Pharmacol. 1996 Apr;36(4):345-51.

PMID:
8728348
34.

Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.

Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL.

Clin Pharmacol Ther. 1996 Apr;59(4):383-8.

PMID:
8612381
35.

Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.

Takimoto CH, Lu ZH, Zhang R, Liang MD, Larson LV, Cantilena LR Jr, Grem JL, Allegra CJ, Diasio RB, Chu E.

Clin Cancer Res. 1996 Mar;2(3):477-81.

36.

Panic disorder in a patient taking oxaprozin.

Hough DW, Sellers R, Cantilena LR.

Am J Psychiatry. 1995 Jan;152(1):149. No abstract available.

PMID:
7802107
37.

Ketoconazole and fluconazole drug interactions.

Honig PK, Cantilena LR.

Arch Intern Med. 1994 May 9;154(9):1038, 1041. No abstract available.

PMID:
8179450
38.

Polypharmacy. Pharmacokinetic perspectives.

Honig PK, Cantilena LR.

Clin Pharmacokinet. 1994 Feb;26(2):85-90. Review. No abstract available.

PMID:
8162659
39.

Population variability in the pharmacokinetics of terfenadine: the case for a pseudo-polymorphism with clinical implications.

Honig PK, Smith JE, Wortham DC, Zamani K, Cantilena LR.

Drug Metabol Drug Interact. 1994;11(2):161-8.

PMID:
12369599
40.

Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics.

Honig PK, Wortham DC, Hull R, Zamani K, Smith JE, Cantilena LR.

J Clin Pharmacol. 1993 Dec;33(12):1201-6.

PMID:
8126255
41.

The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans.

Honig PK, Worham DC, Zamani K, Mullin JC, Conner DP, Cantilena LR.

Clin Pharmacol Ther. 1993 Jun;53(6):630-6.

PMID:
8513654
42.

Procainamide-induced myasthenia-like weakness and dysphagia.

Miller CD, Oleshansky MA, Gibson KF, Cantilena LR.

Ther Drug Monit. 1993 Jun;15(3):251-4.

PMID:
7687390
43.

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR.

JAMA. 1993 Mar 24-31;269(12):1513-8. Erratum in: JAMA 1993 Apr 28;269(16):2088.

PMID:
8445813
44.

Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.

Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR.

Eur J Clin Pharmacol. 1993;45(1):41-6.

PMID:
8405028
45.

Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy.

Cantilena LR Jr, Smith RP, Frasur S, Kruszyna H, Kruszyna R, Wilcox DE.

J Lab Clin Med. 1992 Dec;120(6):902-7.

PMID:
1333513
46.

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.

Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr.

Clin Pharmacol Ther. 1992 Sep;52(3):231-8.

PMID:
1526078
47.

Diurnal and seasonal variation of five carotenoids measured in human serum.

Cantilena LR, Stukel TA, Greenberg ER, Nann S, Nierenberg DW.

Am J Clin Nutr. 1992 Mar;55(3):659-63.

PMID:
1550040
48.

Mercury clearance from human plasma during in vitro dialysis: screening systems for chelating agents.

Ferguson CL, Cantilena LR Jr.

J Toxicol Clin Toxicol. 1992;30(3):423-41.

PMID:
1512815
49.

Enantiomeric analysis of terfenadine in rat plasma by HPLC.

Zamani K, Conner DP, Weems HB, Yang SK, Cantilena LR Jr.

Chirality. 1991;3(6):467-70.

PMID:
1812957
50.

Torsades de pointes occurring in association with terfenadine use.

Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr.

JAMA. 1990 Dec 5;264(21):2788-90.

PMID:
1977935

Supplemental Content

Loading ...
Support Center